IRF3 and cancer: This, in turn, triggers conformational changes in STING, activating TANK-binding kinase 1 (TBK1), which phosphorylates IFN regulatory transcription factor 3 (IRF3) and promotes type I IFN expression in cancer cells or antigen presenting cells.